Results 251 to 260 of about 132,559 (302)

Antibacterial Therapy in Cystic Fibrosis

Medical Clinics of North America, 1990
Bacterial lung infections determine the prognosis for most cystic fibrosis patients. The antibacterial therapy is difficult because of the host-bacterium interaction and altered pharmacokinetics. The new insights in the working mechanisms of antibiotics that may lead to better treatment results have been discussed, and guidelines for treatment of lung ...
J W, Mouton, K F, Kerrebijn
openaire   +2 more sources

The antibacterial therapy of tuberculosis

Tubercle, 1958
Summary Drugs at present available for the treatment of tuberculosis are sufficiently powerful to permit clinical recovery with bacterial negativity and a low relapse rate in almost all patients with active tuberculosis. Some aspects of their use are discussed, with emphasis on possible reasons for the occasional therapeutic failure.
openaire   +2 more sources

Antibacterial photodynamic therapy in dermatology

Photochemical & Photobiological Sciences, 2004
Photodynamic therapy (PDT) appears to be endowed with several favourable features for the treatment of localized microbial infections, especially after the advent of cationic photosensitising agents (phenothiazines, meso-substituted porphyrins, polylysine-bound chlorins) which properly interact with the outer wall at the surface of several types of ...
Tim, Maisch, Rolf-Markus, Szeimies, Giulio, Jori, Christoph, Abels   +3 more
openaire   +2 more sources

Advances in Antibacterial Therapy

Transplantation Proceedings, 2011
Bacterial resistance is still a major concern in antibiotic therapy, especially for immunocompromised and transplantation patients. New therapeutic options are, therefore, needed to overcome the onset of antibiotic resistance. This article reviews the potential role of some antibiotics recently marketed or in clinical development, with a focus on their
openaire   +2 more sources

The importance of the quinolones in antibacterial therapy

Journal of Antimicrobial Chemotherapy, 1990
New quinolones have obtained a definite position in the treatment of certain sexually transmitted diseases, urinary tract infections, prostatitis, gastrointestinal infections, nosocomially acquired pulmonary infections with resistant organisms, pseudomonas infections in cystic fibrosis, and osteomyelitis.
H W, Van Landuyt, K, Magerman, B, Gordts
openaire   +2 more sources

Antibacterial Therapy of Neurosyphilis

CNS Drugs, 2002
Neurosyphilis is caused by the spirochete Treponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen ...
Latisha, Ali, Karen L, Roos
openaire   +2 more sources

Antibacterial Therapy in Pregnancy and Neonates

Clinics in Perinatology, 1997
This article reviews the effects of the physiologic changes accompanying pregnancy on the pharmacokinetics of antimicrobials commonly employed during pregnancy. The possible adverse effects on the fetus from maternal use of antibacterials and their excretion into breast milk are reviewed.
openaire   +2 more sources

Antibacterial Therapy in the Elderly

1978
Before dealing with the more common infections encountered in the elderly, the principles which should guide the prescribing of antibacterials for this group of patients will be discussed.
A. P. Ball, J. A. Gray, J. McM. Murdoch
openaire   +1 more source

Inorganic–organic hybrid nanomaterials for photothermal antibacterial therapy

Coordination Chemistry Reviews, 2023
Xiaoliang Qi, Erya Cai, Xinxin Ge
exaly  

Flourishing Antibacterial Strategies for Osteomyelitis Therapy

Advanced Science, 2023
Xukai Wang, Minglei Zhang, Tongtong Zhu   +2 more
exaly